TrialBMC infectious diseases2014

Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study.

Miriam Estébanez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.